
SOLVE EARLY-STAGE FORMULATION CHALLENGES AND GET TO MARKET FASTER
For NCE product candidates in Phase I or Phase II, Aprecia’s 3DP for Pharma technology opens a new world of powerful formulation solutions and pipeline possibilities. The advantages of Aprecia’s 3DP pharmaceutical manufacturing capabilities for NCEs include:
- Real-time formulation development support for adaptive clinical trials
- Reduced production costs with novel dosage forms that minimize R&D iteration
UNIQUE DOSAGE FORMS TAKE YOUR MEDICINE TO ITS FULLEST POTENTIAL
Aprecia’s unique technology unlocks 3DP dosage forms with unique advantages – giving you new power to make sure your NCE reaches its full therapeutic and market potential.
Developing novel 3DP dosage forms with Aprecia can help you solve formulation challenges through:
- Patent-protected technology for oral dispersible dosage strengths above 275 mg
- Ultra-fast-dissolve capabilities
- Wide range of taste masking capabilities
- Modified drug release
- Pre-gastric drug absorption